
Sign up to save your podcasts
Or
On our Novo Nordisk episode, we covered the business of Ozempic, the GLP-1 taking the world by storm. On this episode, we dive into the science of the molecule semaglutide (and its predecessor liraglutide) with the world expert on the topic, Lotte Bjerre Knudsen. Lotte is Novo Nordisk’s Chief Scientific Advisor, and led the research group back in the early 1990s that first invented the molecule. A few topics from our conversation:
Sponsors:
4.5
222222 ratings
On our Novo Nordisk episode, we covered the business of Ozempic, the GLP-1 taking the world by storm. On this episode, we dive into the science of the molecule semaglutide (and its predecessor liraglutide) with the world expert on the topic, Lotte Bjerre Knudsen. Lotte is Novo Nordisk’s Chief Scientific Advisor, and led the research group back in the early 1990s that first invented the molecule. A few topics from our conversation:
Sponsors:
1,283 Listeners
1,043 Listeners
522 Listeners
4,221 Listeners
1,943 Listeners
2,290 Listeners
796 Listeners
9,264 Listeners
425 Listeners
402 Listeners
352 Listeners
94 Listeners
129 Listeners
125 Listeners
465 Listeners